The Pharmaceutical Development and Operations team at Aerovate Therapeutics is responsible for the end-to-end process of bringing new drugs to market, focusing on rare cardiopulmonary diseases. This includes drug formulation, manufacturing, device engineering, regulatory compliance, quality assurance, and overseeing clinical development operations to ensure high standards and regulatory adherence.
View all